Evidence map›Paper›PMID 41462079›Full record

ArticleMolecular medicine (Cambridge, Mass.)2025

Bulk and single-cell transcriptome analysis reveal shared key genes and patterns of immune dysregulation in systemic lupus erythematosus and sepsis.

Xuehuan Wen, Songjie Bai, Kangwei Sun, Kai Zhang, Ruomeng Hu, Shumin Li, Jie Yang, Lanxin Cao, Zhijian Cai, Gensheng Zhang

Abstract read
In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xuehuan Wen *Department of Oncology, The People's Hospital of Cangnan Zhejiang, Wenzhou Medical University, Wenzhou, Zhejiang, 325800, China.
Songjie Bai *Department of Critical Care Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China.
Kangwei Sun *Department of Critical Care Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China.
Kai Zhang *Department of Critical Care Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China.
Ruomeng Hu *Department of Critical Care Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China.
Shumin LiDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China.
Jie YangDepartment of Critical Care Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China.
Lanxin CaoDepartment of Critical Care Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China.
Zhijian CaiDepartment of Orthopedics of the Second Affiliated Hospital, Institute of Immunology, Zhejiang University School of Medicine, Hangzhou, 310009, China. caizj@zju.edu.cn.
Gensheng ZhangDepartment of Critical Care Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China. genshengzhang@zju.edu.cn.

Funding

Medical and Health Research Programs of Zhejiang Province 2022498722Medical and Health Science and Technology Programs of Zhejiang Province 2025KY323Natural Science Foundation of Zhejiang Province LZ25H150001Zhejiang Provincial Health Major Science and Technology Plan Project WKJ-ZJ-2526
6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) patients often experience sepsis, a significant clinical challenge that frequently requires intensive care and contributes significantly to morbidity and mortality. However, the molecular mechanisms underlying this comorbidity remain poorly understood. This study investigated the molecular intersection of SLE and sepsis using publicly available gene expression datasets. We identified 93 differentially expressed genes (DEGs) (49 upregulated and 44 downregulated) shared by both conditions, primarily impacting bacterial defense and immune response pathways. Integrated differential expression and weighted gene co-expression network analyses (WGCNA) revealed 11 hub genes, with TNFAIP6 and PLSCR1 showing significant diagnostic potential. Single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) revealed a significant expansion of CD14+ monocytes in both conditions, exhibiting elevated expression of the identified hub genes and similar transcriptional profiles. Upregulation of TNFAIP6 and PLSCR1 was validated using public monocyte datasets and real-time PCR of mouse PBMCs, with PLSCR1 showing markedly increased expression in SLE cases complicated by sepsis. Our findings demonstrate that CD14+ monocytes emerge as a common site of immune dysregulation in these comorbid conditions, with overlapping gene expression and pathway alterations suggesting shared molecular mechanisms that could inform targeted therapeutic strategies.

Indexed as

Lupus Erythematosus, SystemicSepsisTranscriptomeAnimalsComputational BiologyGene Expression ProfilingGene Expression RegulationGene Regulatory NetworksHumansLeukocytes, MononuclearMiceMonocytesSingle-Cell AnalysisSingle-Cell Gene Expression AnalysisCD14+ monocytePLSCR1SepsisSingle-cell transcriptomeSystemic lupus erythematosus

Identifiers

PMID41462079
PMCPMC12888134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.